The Pressing Need For Needle-Free Immunization With Heather Callender-Potters

  Immunization is an important subject to talk about, especially in the midst of a pandemic like COVID-19. While traditional immunization methods are popular as ever, more and more companies are seeking out methods for needle-free immunization that mitigate some of the risks presented by needle immunization. Bob Roark is joined by https://www.linkedin.com/in/heather-callender-potters-62247/ (Heather Callender-Potters), the Co-Founder of https://pharmajet.com/ (PharmaJet), to discuss the pressing impetus for investing more resources into needle-free immunization. Let Bob and Heather take you through this vital topic with a spirited conversation. --- Watch the episode here:[embed]https://www.youtube.com/watch?v=zYQTMdkD5qI[/embed] Listen to the podcast here:[smart_track_player url="" title="The Pressing Need For Needle-Free Immunization With Heather Callender-Potters" image="http://businessleaderspodcast.com/wp-content/uploads/2018/04/BLP-SquareLogo-WhiteBlueBG1400x1400.png" background="default"] The Pressing Need For Needle-Free Immunization With Heather Callender-PottersMy guest is Heather Potters. She's the Vice Chairman, Global Business Development Officer, and Cofounder of https://pharmajet.com/ (PharmaJet). Welcome, Heather. It's exciting for me. Thank you. I'm so excited to have this time with you and get your story out there, which it's already out there, but at least through this channel. If you could talk about PharmaJet's vision and your vision is needle-free applications for immunization and the story of why you started there and why that's still your focus. My mother and me cofounded the business. We wanted to make sure that we made a contribution to healthcare. She had experienced needles, she'd seen reused and there was a call to action by the World Health Organization because they were witnessing needle reuse about whether or not somebody could develop a needle-free immunization tool. We decided to rise to that occasion. When we looked at the market, immunization is global. We all s